array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(661) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(145) "Bio-Rad launches first Ultrasensitive Multiplexed Digital PCR Assay for breast cancer mutation detection in clinical research | Cambridge Network" ["snippet_en"]=> string(204) "Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600TM Droplet DigitalTM PCR System" ["url"]=> string(130) "https://www.cambridgenetwork.co.uk/news/bio-rad-launches-first-ultrasensitive-multiplexed-digital-pcr-assay-breast-cancer-mutation" ["image_url"]=> NULL ["source"]=> string(22) "cambridgenetwork.co.uk" ["publication_date"]=> string(10) "2024-04-03" ["categories"]=> array(4) { [0]=> string(5) "Legal" [1]=> string(10) "New Market" [2]=> string(5) "R & D" [3]=> string(14) "Product Launch" } } [1]=> array(7) { ["title_en"]=> string(150) "Protein expression of nucleolar protein 12 in the retina and its implication in protection of retina from UV irradiation damage - Cell Death Discovery" ["snippet_en"]=> string(299) "Nucleolar protein 12 (NOL12), one of the nucleolar proteins which are primarily expressed in the nucleolus and play key roles in RNA metabolism, cell proliferation, cell cycle, and cell survival, is widely expressed in various species and multiple organs. Although it has been reported that the mRNA" ["url"]=> string(50) "https://www.nature.com/articles/s41420-024-01902-x" ["image_url"]=> string(78) "https://images.businessradar.com/articles/371d596c-6a91-4aaf-8442-5ef2fd4a0c30" ["source"]=> string(10) "nature.com" ["publication_date"]=> string(10) "2024-03-11" ["categories"]=> array(2) { [0]=> string(5) "Legal" [1]=> string(11) "Acquisition" } } [2]=> array(7) { ["title_en"]=> string(97) "Oxidized SOD1 accelerates cellular senescence in neural stem cells - Stem Cell Research & Therapy" ["snippet_en"]=> string(294) "Background Neural stem cells (NSCs), especially human NSCs, undergo cellular senescence characterized by an irreversible proliferation arrest and loss of stemness after prolonged culture. While compelling correlative data have been generated to support the oxidative stress theory as one of the" ["url"]=> string(73) "https://stemcellres.biomedcentral.com/articles/10.1186/s13287-024-03669-5" ["image_url"]=> string(78) "https://images.businessradar.com/articles/092b7b28-141d-407b-b459-b4d8f560490f" ["source"]=> string(17) "biomedcentral.com" ["publication_date"]=> string(10) "2024-02-27" ["categories"]=> array(2) { [0]=> string(17) "Academic Research" [1]=> string(5) "Legal" } } [3]=> array(7) { ["title_en"]=> string(56) "Bio-Rad Attorney Wins $11 Million in Whistleblower Trial" ["snippet_en"]=> string(226) "A federal jury Monday awarded the former general counsel of Bio-Rad Laboratories $8 million in back pay and damages — which will increase to $11 million — for whistleblower retaliation involving potential bribery in China." ["url"]=> string(86) "https://www.courthousenews.com/biorad-attorney-wins-11-million-in-whistleblower-trial/" ["image_url"]=> NULL ["source"]=> string(18) "courthousenews.com" ["publication_date"]=> string(10) "2023-11-10" ["categories"]=> array(11) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(19) "Economic Conditions" [2]=> string(10) "Misconduct" [3]=> string(7) "Scandal" [4]=> string(7) "Bribery" [5]=> string(8) "Verdicts" [6]=> string(15) "Business Ethics" [7]=> string(15) "Corporate Fines" [8]=> string(20) "Corporate Governance" [9]=> string(5) "Legal" [10]=> string(16) "Case Settlements" } } [4]=> array(7) { ["title_en"]=> string(77) "IT & Admin Services to Indian Affiliate by Singapore Entity Not FTS: Delhi HC" ["snippet_en"]=> string(194) "Delhi High Court rules on income tax and administrative services provided by a Singapore entity to its Indian affiliate. Analysis of the case Commissioner of Income Tax vs. Bio-Rad Laboratories." ["url"]=> string(99) "https://taxguru.in/income-tax/it-admin-services-indian-affiliate-singapore-entity-fts-delhi-hc.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/24a4d8e8-44c2-4c96-a182-8547617532ae" ["source"]=> string(10) "taxguru.in" ["publication_date"]=> string(10) "2023-11-10" ["categories"]=> array(7) { [0]=> string(11) "Legislation" [1]=> string(10) "Tax Havens" [2]=> string(15) "Business Ethics" [3]=> string(11) "Tax evasion" [4]=> string(5) "Legal" [5]=> string(5) "Taxes" [6]=> string(46) "Management of Legal and Regulatory Environment" } } [5]=> array(7) { ["title_en"]=> string(66) "Bio-Rad’s Patent Threats Draw Suit to Clear Cancer-Research Test" ["snippet_en"]=> string(240) "Bio-Rad Laboratories Inc. was hit with a lawsuit alleging its threats of patent-infringement litigation over ChromaCode Inc.'s high-definition genetic test used in cancer research is “a sword of Damocles over” the small biotech company." ["url"]=> string(100) "https://news.bloomberglaw.com/ip-law/bio-rads-patent-threats-draw-suit-to-clear-cancer-research-test" ["image_url"]=> string(78) "https://images.businessradar.com/articles/db5d5e00-c873-474f-ada6-fa348923ef27" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2023-09-21" ["categories"]=> array(4) { [0]=> string(5) "Legal" [1]=> string(10) "Litigation" [2]=> string(5) "R & D" [3]=> string(27) "Business Model & Innovation" } } [6]=> array(7) { ["title_en"]=> string(75) "Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement" ["snippet_en"]=> string(300) "Hercules, Calif., and Venlo, the Netherlands, July 26, 2023( GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc.( NYSE: BIO and BIOb) and QIAGEN N.V.( NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court" ["url"]=> string(76) "https://finance.yahoo.com/news/bio-rad-qiagen-announce-patent-201500562.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3d3721dc-43e4-4795-87db-f774b7c41b35" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-07-26" ["categories"]=> array(5) { [0]=> string(27) "Business Model & Innovation" [1]=> string(5) "Legal" [2]=> string(21) "Intellectual Property" [3]=> string(46) "Management of Legal and Regulatory Environment" [4]=> string(16) "Case Settlements" } } [7]=> array(7) { ["title_en"]=> string(75) "Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement" ["snippet_en"]=> string(197) "Hercules, Calif., and Venlo, the Netherlands, July 26, 2023 (GLOBE NEWSWIRE) — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today..." ["url"]=> string(165) "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2023/07/26/439908/bio-rad-and-qiagen-announce-patent-settlement-and-cross-licensing-agreement/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5754d4ca-b8d3-4c18-a04d-7b4502c29676" ["source"]=> string(11) "sina.com.hk" ["publication_date"]=> string(10) "2023-07-26" ["categories"]=> array(4) { [0]=> string(16) "Case Settlements" [1]=> string(5) "Legal" [2]=> string(13) "Collaboration" [3]=> string(27) "Business Model & Innovation" } } [8]=> array(7) { ["title_en"]=> string(68) "10x Genomics Stock: The Illumina of Single-Cell Analysis? - Nanalyze" ["snippet_en"]=> string(289) "The United States is famously the most litigious society in the world. One statistic we’ve come across is that the country spends about $310 billion a year on litigation. One particularly well-known American has been involved in some 3,500 lawsuits, perhaps skewing the statistics a bit." ["url"]=> string(67) "https://www.nanalyze.com/2023/06/10x-genomics-single-cell-analysis/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bfd907d9-d7f8-489a-aa19-b43d57ad5e65" ["source"]=> string(12) "nanalyze.com" ["publication_date"]=> string(10) "2023-06-19" ["categories"]=> array(2) { [0]=> string(5) "Legal" [1]=> string(10) "Litigation" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(31) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(28) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(26) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [9]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(13) } [15]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc